Nuclease-Resistant Sequencing Primer for Single-Step PCR Cleanup

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Standard PCR/sequencing workflows require additional reagent addition steps for cleanup, increasing labor, error risk, and automation challenges due to excess amplification primers and dNTPs, leading to aberrant sequence ladders and weak sequencing signals.

Innovation Solution

A method utilizing nuclease-resistant sequencing primers that degrade excess amplification primers, allowing for a single-step PCR/sequencing process without a separate cleanup step, using a nuclease-resistant sequencing primer that is not susceptible to exonuclease cleavage, enabling direct addition of sequencing reagents to PCR products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a standard PCR/sequencing workflow is used with cleanup steps, then sequencing accuracy is maintained, but the process complexity and labor requirements increase

Engineering Contradiction:
Improvesequencing accuracyVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines the PCR amplification and sequencing reactions into a single unified workflow by using amplification primers with different chemical properties (nuclease-sensitive vs nuclease-resistant). The nuclease-sensitive amplification primers are degraded during the sequencing reaction, while the nuclease-resistant sequencing primers remain intact, allowing both reactions to occur in the same tube without requiring separate cleanup steps.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent applies different chemical modifications to different primers within the same reaction system. Amplification primers are designed to be nuclease-sensitive while sequencing primers are made nuclease-resistant through chemical modification. This local differentiation in chemical properties allows the system to automatically distinguish between amplification and sequencing functions without additional processing steps.

Inventive Principle:
Principle #3Local quality

2Productivity

If excess amplification primers are not removed before sequencing, then the workflow is simplified, but aberrant sequence ladders and sequencing errors occur

Engineering Contradiction:
Improveworkflow efficiencyVSAvoidsequencing accuracy
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent selectively removes excess amplification primers from the reaction mixture by exploiting their nuclease sensitivity. During the sequencing reaction, nucleases degrade the nuclease-sensitive amplification primers while leaving the nuclease-resistant sequencing primers and amplification products intact, effectively extracting the harmful excess primers in situ.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the potential harm of excess amplification primers into a beneficial selection mechanism. By making amplification primers nuclease-sensitive and sequencing primers nuclease-resistant, the system uses nuclease activity to selectively eliminate amplification primers while preserving sequencing primers, turning what would be interference into a useful purification step.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Manufacturing precision

If multiple reagent addition steps are required, then reagent purity is maintained, but the time required for sample preparation increases

Engineering Contradiction:
Improvereagent purityVSAvoidpreparation time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent merges multiple separate reagent addition steps (PCR reagents and sequencing reagents) into a single combined reaction mixture. By designing primers with differential nuclease sensitivity, the system maintains functional separation of amplification and sequencing reagents while physically combining them in one tube, eliminating sequential addition steps and reducing preparation time.

Inventive Principle:
Principle #5Merging (Combining)

4Reliability

If nuclease treatment is applied to remove excess primers, then sequencing quality improves, but the risk of degrading sequencing reagents increases

Engineering Contradiction:
Improvesequencing qualityVSAvoidreagent degradation risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies nuclease resistance selectively to sequencing primers through chemical modification, while leaving amplification primers nuclease-sensitive. This local quality differentiation protects sequencing reagents from nuclease degradation while allowing excess amplification primers to be removed, eliminating the risk of sequencing reagent damage.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach simplifies the workflow, reduces processing steps, and generates clean, accurate sequencing data by eliminating the need for extra reagent additions, thereby reducing errors and improving automation feasibility.

Implementation Method 1

contacting the amplification reaction products with a reaction mixture comprising a nuclease and a nuclease-resistant sequencing primer, under conditions in which the excess amplification primer is degraded by the nuclease

Methodology Applied
Scientific EffectNuclease cleavage: Hydrolysis

Implementation Method 2

The hydrolytic properties of exonuclease I degrade single-stranded DNA present in the PCR mixture allowing the amplification product (amplicon) to be used more efficiently in subsequent sequencing applications

Methodology Applied
Scientific EffectHydrolytic degradation: Hydrolysis

Implementation Method 3

The enzyme activity of alkaline phosphatase dephosphorylates dNTPs remaining from the PCR reaction

Methodology Applied
Scientific EffectDephosphorylation: Hydrolysis

Data Source

PatentEP2489744B1Composition and method for sequencing nucleic acid
Publication Date: 2014.09.03 LIFE TECHNOLOGIES CORP
  • EP2489744B1 patent drawingFigure 1
  • EP2489744B1 patent drawingFigure 2
  • EP2489744B1 patent drawingFigure 3

AI summary

A composition for sequencing DNA is provided and comprises a nuclease and a nuclease-resistant sequencing primer. A method of preparing DNA for sequencing and a method of sequencing DNA are also provided. The method of sequencing DNA can comprise contacting amplification reaction products with the composition under conditions in which excess amplification primer is degraded by the nuclease and the nuclease-resistant sequencing primer is essentially non-degraded.